Molecular Partners Updates Pipeline As MP0712 Dosing Continues, NuMeRI Initiates Compassionate Care With 225Ac DLL3 Radio-DARPin, And MP0726 Imaging Targeted For Second Half Of 2026

Loading news article.

Molecular Partners Updates Pipeline As MP0712 Dosing Continues, NuMeRI Initiates Compassionate Care With 225Ac DLL3 Radio-DARPin, And MP0726 Imaging Targeted For Second Half Of 2026 | WAPE

Molecular Partners Updates Pipeline As MP0712 Dosing Continues, NuMeRI Initiates Compassionate Care With 225Ac DLL3 Radio-DARPin, And MP0726 Imaging Targeted For Second Half Of 2026

Article summary

Related companies

Comments —